• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用 Sprint Fidelis 电极的患者中被动固定导联失败率和长期患者死亡率。

Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.

机构信息

Division of Clinical Electrophysiology, Department of Cardiology and Pneumology, University Medical Center Göttingen, Georg-August-University, Robert-Koch-Str. 40, 37075 Göttingen, Germany.

出版信息

Europace. 2014 Feb;16(2):258-64. doi: 10.1093/europace/eut185. Epub 2013 Jun 28.

DOI:10.1093/europace/eut185
PMID:23813451
Abstract

AIMS

To evaluate passive-fixation lead failure rates and long-term patient survival in subjects implanted with Sprint Fidelis electrodes.

METHODS AND RESULTS

We identified 748 subjects who received a Sprint Fidelis (n = 429; Medtronic models 6948: 94.8%, 6949: 2.6%, 6930: 1.9%, 6931: 0.7%) or a Sprint 'non-Fidelis' implantable cardioverter defibrillator lead (n = 319, Medtronic models 6944: 68.6%, 6947: 17.9%, 6942: 7.8%, 6943: 3.4%, 6945: 2.2%) at our centre between 1998 and 2008. Kaplan-Meier patient survival was lower in the Fidelis group than in the Control cohort (68.4 vs. 77.0% at 5 years, P = 0.0061), but multivariate analyses revealed no significant association between mortality and implanted lead type. Passive-fixation lead failure rate at 5 years was 14.4% (95% confidence interval (CI) [9.2, 19.3]) in the Fidelis (n = 414) group and 1.8% (95% CI [0.0-3.8]) in the Control (n = 241) cohort (P < 0.001 upon multivariate comparison).

CONCLUSION

Failure rates of passive-fixation Sprint Fidelis leads are increased and similar to those previously reported for active-fixation Fidelis electrodes. Despite the elevated risk for lead failure and its potential sequelae, the Sprint Fidelis has no obvious impact on long-term mortality.

摘要

目的

评估植入 Sprint Fidelis 电极的患者中被动固定导联的失败率和长期患者生存率。

方法和结果

我们确定了 748 名在我们中心接受 Sprint Fidelis(n = 429;Medtronic 模型 6948:94.8%,6949:2.6%,6930:1.9%,6931:0.7%)或 Sprint 非 Fidelis 植入式心脏复律除颤器导联植入的患者(n = 319,Medtronic 模型 6944:68.6%,6947:17.9%,6942:7.8%,6943:3.4%,6945:2.2%)。在我们中心接受 Sprint Fidelis 或 Sprint 非 Fidelis 植入式心脏复律除颤器导联植入的患者,在我们中心接受 Sprint Fidelis 或 Sprint 非 Fidelis 植入式心脏复律除颤器导联植入的患者,Kaplan-Meier 患者生存率在 Fidelis 组低于对照组(5 年时 68.4%对 77.0%,P = 0.0061),但多变量分析显示死亡率与植入导联类型之间无显著关联。在 Fidelis 组(n = 414)和对照组(n = 241)中,5 年时被动固定导联失败率分别为 14.4%(95%置信区间(CI)[9.2,19.3])和 1.8%(95%CI [0.0-3.8])(多变量比较时 P < 0.001)。

结论

被动固定 Sprint Fidelis 导联的失败率增加,与之前报道的主动固定 Fidelis 电极相似。尽管被动固定 Sprint Fidelis 导联失败风险增加及其潜在后果,但对长期死亡率无明显影响。

相似文献

1
Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.采用 Sprint Fidelis 电极的患者中被动固定导联失败率和长期患者死亡率。
Europace. 2014 Feb;16(2):258-64. doi: 10.1093/europace/eut185. Epub 2013 Jun 28.
2
Factors predicting Sprint Fidelis lead fracture: Results at 5 years from a French multicentre registry.预测 Sprint Fidelis 导线断裂的因素:来自法国多中心注册研究的 5 年结果
Arch Cardiovasc Dis. 2015 Apr;108(4):220-6. doi: 10.1016/j.acvd.2014.11.006. Epub 2015 Apr 6.
3
Long-term performance of the Medtronic Sprint Fidelis lead: a matter of lead type?美敦力 Sprint Fidelis 导联的长期性能:与导联类型有关吗?
Europace. 2012 Nov;14(11):1620-3. doi: 10.1093/europace/eus181. Epub 2012 Jun 15.
4
Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.Sprint Fidelis 除颤器导联故障的风险高度依赖于年龄。
Arch Cardiovasc Dis. 2011 Jun-Jul;104(6-7):388-95. doi: 10.1016/j.acvd.2011.05.002. Epub 2011 Jul 8.
5
A single-centre experience concerning the safety of Sprint Fidelis defibrillator lead extraction at the time of pulse generator replacement or in case of evidence of lead failure.在更换脉冲发生器时或出现导联故障证据时,单次中心经验涉及 Sprint Fidelis 除颤器导联提取的安全性。
Arch Cardiovasc Dis. 2012 Apr;105(4):203-10. doi: 10.1016/j.acvd.2012.01.007. Epub 2012 Apr 3.
6
Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.植入式心脏复律除颤器和 Sprint Fidelis 导联患者的临床结局。
Heart. 2013 Jun;99(11):799-804. doi: 10.1136/heartjnl-2012-303259. Epub 2013 Feb 22.
7
Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.Sprint Fidelis 与 Riata 除颤器导联故障发生率比较。
Int J Cardiol. 2013 Sep 30;168(2):848-52. doi: 10.1016/j.ijcard.2012.10.015. Epub 2012 Nov 6.
8
Failure of implantable cardioverter-defibrillator leads: a matter of lead size?植入式心脏复律除颤器导线故障:导线尺寸的问题?
Heart Rhythm. 2013 Feb;10(2):184-90. doi: 10.1016/j.hrthm.2012.10.017. Epub 2012 Oct 11.
9
Failure-free survival of the Durata defibrillator lead.Durata 除颤器导联无故障存活。
Europace. 2013 Jul;15(7):1002-6. doi: 10.1093/europace/eut010. Epub 2013 Feb 1.
10
Update on small-diameter implantable cardioverter-defibrillator leads performance.小直径植入式心脏复律除颤器导线性能的最新进展。
Pacing Clin Electrophysiol. 2012 Jun;35(6):652-8. doi: 10.1111/j.1540-8159.2011.03338.x. Epub 2012 Feb 21.

引用本文的文献

1
Long-Term Performance of Epicardial versus Transvenous Left Ventricular Leads for Cardiac Resynchronization Therapy.用于心脏再同步治疗的心外膜与经静脉左心室导线的长期性能
J Clin Med. 2023 Sep 5;12(18):5766. doi: 10.3390/jcm12185766.
2
Impact of fracture-prone implantable cardioverter defibrillator leads on long-term patient mortality.易发生骨折的植入式心脏复律除颤器导线对患者长期死亡率的影响。
J Arrhythm. 2023 Mar 26;39(3):454-463. doi: 10.1002/joa3.12843. eCollection 2023 Jun.
3
Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.
经静脉植入式心脏复律除颤器(ICD)导线性能:观察性研究的荟萃分析
J Am Heart Assoc. 2015 Oct 30;4(11):e002418. doi: 10.1161/JAHA.115.002418.